Table 4

Change From Baseline in FDG Uptake in Subcutaneous and Visceral Fat

Change From Baseline in Average Maximum SUV for Subcutaneous Fat
GroupMean ± SD SUVDay 84 Versus BaselinePlacebo and Baseline Corrected
BaselineDay 84Difference95% CIp ValueDifference95% CIp Value
HD, n = 330.32 ± 0.0850.30 ± 0.095−0.02−0.05 to 0.000.060−0.00−0.04 to 0.030.815
LD, n = 320.34 ± 0.0840.31 ± 0.079−0.03−0.05 to −0.000.020−0.01−0.05 to 0.030.636
Placebo, n = 300.34 ± 0.1120.32 ± 0.108−0.02−0.05 to 0.010.168NANANA
Change From Baseline in Average Maximum SUV for Visceral Fat
GroupMean ± SD SUVDay 84 Versus BaselinePlacebo and Baseline Corrected
BaselineDay 84Difference95% CIp ValueDifference95% CIp Value
HD, n = 330.59 ± 0.1100.53 ± 0.120−0.06−0.09 to −0.020.002−0.05−0.09 to −0.010.018
LD, n = 320.58 ± 0.1330.56 ± 0.140−0.02−0.06 to 0.020.274−0.02−0.06 to 0.030.502
Placebo, n = 300.57 ± 0.1300.57 ± 0.081−0.01−0.03 to 0.020.654NANANA

SUV = standard uptake value; other abbreviations as in Tables 1 and 2.

  • Difference, 95% CI, and p value for comparison derived from analysis of covariance.